Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.

Antimicrobial Agents and Chemotherapy
P StapletonI Phillips

Abstract

Among Escherichia coli organisms isolated at St. Thomas's Hospital during the years 1990 to 1994, the frequency of resistance to amoxicillin-clavulanic acid (tested by disk diffusion in a ratio of 2:1) remained constant at about 5% of patient isolates (10 to 15% of the 41 to 45% that were amoxicillin resistant). Mechanisms of increased resistance were determined for 72 consecutively collected such amoxicillin-clavulanic acid-resistant isolates. MICs of the combination were 16-8 micrograms/ml for 51 (71%) of these and > or = 32-16 micrograms/ml for the remainder. The predominant mechanism was hyperproduction of enzymes isoelectrically cofocusing with TEM-1 (beta-lactamase activities, > 200 nmol of nitrocefin hydrolyzed per min per mg of protein) which was found in 44 isolates (61%); two isolates produced smaller amounts (approximately 150 nmol/min/mg) of such enzymes, and two isolates hyperproduced enzymes cofocusing with TEM-2. Eleven isolates produced enzymes cofocusing with OXA-1 beta-lactamase, which has previously been associated with resistance to amoxicillin-clavulanic acid. Ten isolates produced increased amounts of chromosomal beta-lactamase, and four of these additionally produced TEM-1 or TEM-2. Three isolates produce...Continue Reading

References

Aug 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J G Sutcliffe
May 1, 1977·Antimicrobial Agents and Chemotherapy·C Reading, M Cole
Mar 1, 1992·FEMS Microbiology Letters·C J Thomson, S G Amyes
Dec 1, 1992·The Journal of Antimicrobial Chemotherapy·P J WuI Phillips
Nov 1, 1992·The Journal of Antimicrobial Chemotherapy·K ShannonI Phillips
May 1, 1991·The Journal of Antimicrobial Chemotherapy·J A RegueraJ L Martínez
May 15, 1991·The Biochemical Journal·R P AmblerS G Waley
Mar 1, 1989·Antimicrobial Agents and Chemotherapy·K Bush
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A R Oliphant, K Struhl
Nov 1, 1989·The Journal of Antimicrobial Chemotherapy·B WiedemannM Kresken
Nov 1, 1989·The Journal of Antimicrobial Chemotherapy·C RoyM Hermida
Dec 19, 1987·Lancet·J L MartinezF Baquero
Mar 26, 1988·Lancet·G French, T Ling
Dec 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J A RegueraJ L Martinez
Jul 1, 1994·The Journal of Antimicrobial Chemotherapy·T K LingG L French

❮ Previous
Next ❯

Citations

Oct 8, 1999·Pharmacology & Therapeutics·Y YangD M Shlaes
Jan 9, 2004·Diagnostic Microbiology and Infectious Disease·Jacques Albert DromignyJean David Perrier-Gros-Claude
Jul 24, 2002·International Journal of Antimicrobial Agents·F M E WagenlehnerK G Naber
Dec 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·V SiderakiH F Gilbert
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A Bonomo
Jan 14, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Amel BellaajKamel Ben-Mahrez
Feb 22, 2003·Surgical Infections·C E EdmistonG R Seabrook
Jun 1, 1999·The Journal of Antimicrobial Chemotherapy·E B ChaïbiR Labia
Apr 1, 1996·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·T M LeegaardJ A van de Klundert
Aug 10, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·L K SiuP Y Chau
Jun 19, 2008·Antimicrobial Agents and Chemotherapy·Christopher R BethelRobert A Bonomo
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·K S KayeY Carmeli
Sep 18, 2002·Antimicrobial Agents and Chemotherapy·Laura BriñasCarmen Torres
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Antonio OliverFred C Tenover
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Sergei Vakulenko, Dasantila Golemi
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Dearbháile MorrisMartin Cormican
Sep 25, 2004·Antimicrobial Agents and Chemotherapy·Roberto CabreraJordi Vila
Oct 27, 2004·Antimicrobial Agents and Chemotherapy·Véronique DuboisClaudine Quentin
Nov 11, 2008·Applied and Environmental Microbiology·Karen L LachmayrTimothy E Ford
Jun 7, 2005·Expert Opinion on Emerging Drugs·Florian M E WagenlehnerKurt G Naber
Dec 7, 2010·International Journal of Antimicrobial Agents·G L French
Nov 3, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Griangsak EumkebSupatcharee Siriwong
Nov 13, 2007·International Journal of Antimicrobial Agents·F M E WagenlehnerK G Naber
Dec 7, 2007·The Urologic Clinics of North America·F M E WagenlehnerK G Naber
Jul 23, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Gwen DuytschaeverPeter Vandamme
Mar 5, 2004·Journal of Chemotherapy·S G B Amyes
Jun 1, 1997·Journal of Chemotherapy·P BallG Rolinson
Aug 28, 1999·Journal of Chemotherapy·V Fanos, B J Khoory
Oct 12, 1999·Clinics in Chest Medicine·L A Mandell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.